drugset / Trial / NCT03716622
A Comparison of Clarithromycin-based and Furazolidone-based Bismuth-containing Regimens for H. Pylori Eradication
RandomizedCrossoverOpen-labelTreatment
Summary
We aim to assess and compare the effectiveness of clarithromycin- and furazolidone-based regimens as primary therapies in eradicating H. pylori.
Timeline
- Start
- 2018-07-31
- Primary completion
- 2019-08-31
- Completion
- 2019-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clarithromycin | Small molecule | 500 mg | Oral |
| Subject | Furazolidone | Small molecule | 100 mg | Oral |